3 Reasons Why Growth Investors Shouldn't Overlook Electromed (ELMD)

Core Viewpoint - Growth investors are attracted to stocks with above-average financial growth, but identifying such stocks can be challenging due to their inherent risks and volatility [1] Group 1: Company Overview - Electromed, Inc. (ELMD) is highlighted as a promising growth stock, possessing a favorable Growth Score and a top Zacks Rank [2] - The company has a historical EPS growth rate of 31.3%, with projected EPS growth of 25.9% this year, surpassing the industry average of 19.7% [5] Group 2: Financial Metrics - Electromed's year-over-year cash flow growth stands at 48.9%, significantly higher than the industry average of -0.9% [6] - The company's annualized cash flow growth rate over the past 3-5 years is 12.7%, compared to the industry average of 6.3% [7] Group 3: Earnings Estimates - The current-year earnings estimates for Electromed have been revised upward, with the Zacks Consensus Estimate increasing by 2.9% over the past month [9] - Electromed has achieved a Growth Score of B and a Zacks Rank 2 due to positive earnings estimate revisions [10]